Showing 1 - 16 results of 16 for search 'Chengcheng Gong', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer by Shuhui You, Shuhui You, Chengcheng Gong, Chengcheng Gong, Yi Li, Yizhao Xie, Yumeng Li, Yumeng Li, Yannan Zhao, Yannan Zhao, Biyun Wang, Biyun Wang
Published 2023-10-01
Article -
5
Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study by Yannan Zhao, Cheng Liu, Yingjian Zhang, Chengcheng Gong, Yi Li, Yizhao Xie, Bingrui Wu, Zhongyi Yang, Biyun Wang
Published 2018-09-01
Article -
6
A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer by Yi Li, Wei Li, Chengcheng Gong, Yabin Zheng, Quchang Ouyang, Ning Xie, Qing Qu, Rui Ge, Biyun Wang
Published 2021-06-01
Article -
7
DNA methylation suppresses chitin degradation and promotes the wing development by inhibiting Bmara-mediated chitinase expression in the silkworm, Bombyx mori by Guanfeng Xu, Yangqin Yi, Hao Lyu, Chengcheng Gong, Qili Feng, Qisheng Song, Xuezhen Peng, Lin Liu, Sichun Zheng
Published 2020-09-01
Article -
8
Clinicopathological characteristics, evolution, and treatment outcomes of hormone receptor-negative/HER2-low metastatic breast cancer: a pooled analysis of individual patient data... by Shihui Hu, Shihui Hu, Yannan Zhao, Yannan Zhao, Yizhao Xie, Yizhao Xie, Shuhui You, Shuhui You, Xichun Hu, Xichun Hu, Jian Zhang, Jian Zhang, Leiping Wang, Leiping Wang, Jun Cao, Jun Cao, Chengcheng Gong, Chengcheng Gong, Biyun Wang, Biyun Wang
Published 2024-11-01
Article -
9
-
10
Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study by Yi Li, Chengcheng Gong, Qianyi Lu, Zhaochun Zhou, Ting Luo, Wei Li, Gang Li, Rui Ge, Fei Xu, Biyun Wang
Published 2020-03-01
Article -
11
ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors by Shuhui You, Yizhao Xie, Mengjing Ji, Cheng Liu, Yannan Zhao, Chengcheng Gong, Shihui Hu, Yumeng Li, Zhongyi Yang, Biyun Wang
Published 2023-12-01
Article -
12
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data by Chengcheng Gong, Yizhao Xie, Yannan Zhao, Yi Li, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Xichun Hu, Biyun Wang
Published 2022-12-01
Article -
13
-
14
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases by Yizhao Xie, Chengcheng Gong, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Yannan Zhao, Yi Li, Shihui Hu, Biyun Wang, Xichun Hu
Published 2021-11-01
Article -
15
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients by Zhonghua Tao, Zhonghua Tao, Ting Li, Ting Li, Zhe Feng, Zhe Feng, Chang Liu, Chang Liu, Yilin Shao, Yilin Shao, Mingyu Zhu, Mingyu Zhu, Chengcheng Gong, Chengcheng Gong, Biyun Wang, Biyun Wang, Jun Cao, Jun Cao, Leipin Wang, Leipin Wang, Yiqun Du, Yiqun Du, Analyn Lizaso, Bing Li, Jian Zhang, Jian Zhang, Xichun Hu, Xichun Hu
Published 2020-06-01
Article -
16
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study by Yannan Zhao, Ning Xie, Wei Li, Wenyan Chen, Zheng Lv, Yabing Zheng, Tao Sun, Jieqiong Liu, Jian Zhang, Shihui Hu, Yajun Wang, Chengcheng Gong, Yi Li, Yizhao Xie, Rui Ge, Fei Xu, Biyun Wang
Published 2021-07-01
Article